Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...

Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...

Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.

A 5-year-old boy with a neuroblastoma developed PAH after receiving a high dose of chemotherapy to prepare for a stem cell ...

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...

People with portopulmonary hypertension (PoPH) show lower survival rates than other PAH types, but targeted PAH treatments ...

To reduce fatigue, the first thing columnist Jen Cueva did was analyze her sleep patterns, revealing some surprising results.

A heart ultrasound measure called tricuspid regurgitation could show risk, especially in those considered low risk, based on other measures.

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...

View this post on Instagram Day 6 of 30 Days of PH⁣⠀ ⁣⠀ Topic: Single Mom ⁣⠀ This is Monica’s story @evilqueenmoni74⁣⠀ ⁣⠀ In 2004 I was a single mom of my 6 1/2-year-old daughter, Sadie. I made an ...